Rosuvastatin Completed Phase 2 Trials for Systemic Lupus Erythematosus (SLE) / Atherosclerosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01170585A Trial of Rosuvastatin in Systemic Lupus Erythematosus